Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,735Revenue (TTM) $M1,023Net Margin (%)14.7Altman Z-Score9.9
Enterprise Value $M20,075EPS (TTM) $0.8Operating Margin %16.4Piotroski F-Score6
P/E(ttm)135Beneish M-Score-1.3Pre-tax Margin (%)15.0Higher ROA y-yY
Price/Book54.410-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales20.15-y EBITDA Growth Rate %--Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow121y-y EBITDA Growth Rate %2,941ROA % (ttm)12.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)65.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M188ROIC % (ttm)102Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INCYJoel Greenblatt 2016-09-30 Reduce-0.03%$76.11 - $94.29
($84.26)
$ 104.7624%Reduce -24.20%108,099
INCYGeorge Soros 2016-09-30 Reduce-0.01%$76.11 - $94.29
($84.26)
$ 104.7624%Reduce -30.67%5,200
INCYKen Fisher 2016-09-30 Add$76.11 - $94.29
($84.26)
$ 104.7624%Add 0.67%14,917
INCYJoel Greenblatt 2016-06-30 Add0.09%$68.69 - $87.71
($77.54)
$ 104.7635%Add 171.63%142,607
INCYGeorge Soros 2016-06-30 Buy 0.02%$68.69 - $87.71
($77.54)
$ 104.7635%New holding7,500
INCYKen Fisher 2016-06-30 Reduce$68.69 - $87.71
($77.54)
$ 104.7635%Reduce -0.14%14,818
INCYVanguard Health Care Fund 2016-03-31 Add1.06%$63.05 - $108.45
($75)
$ 104.7640%Add 68.76%16,227,748
INCYJoel Greenblatt 2016-03-31 Buy 0.04%$63.05 - $108.45
($75)
$ 104.7640%New holding52,500
INCYGeorge Soros 2016-03-31 Sold Out -0.01%$63.05 - $108.45
($75)
$ 104.7640%Sold Out0
INCYKen Fisher 2016-03-31 Add$63.05 - $108.45
($75)
$ 104.7640%Add 0.14%14,839
INCYVanguard Health Care Fund 2015-12-31 Add0.08%$100.21 - $126.46
($111.45)
$ 104.76-6%Add 4.15%9,615,828
INCYGeorge Soros 2015-12-31 Buy 0.01%$100.21 - $126.46
($111.45)
$ 104.76-6%New holding4,200
INCYJoel Greenblatt 2015-12-31 Sold Out -0.01%$100.21 - $126.46
($111.45)
$ 104.76-6%Sold Out0
INCYKen Fisher 2015-12-31 Add$100.21 - $126.46
($111.43)
$ 104.76-6%Add 2.23%14,818
INCYVanguard Health Care Fund 2015-09-30 Reduce-0.04%$95.16 - $131.47
($112.12)
$ 104.76-7%Reduce -1.90%9,233,028
INCYJoel Greenblatt 2015-09-30 Reduce-0.01%$95.16 - $131.47
($112.12)
$ 104.76-7%Reduce -53.09%4,861
INCYKen Fisher 2015-09-30 Add$95.16 - $131.47
($112.12)
$ 104.76-7%Add 5.84%14,495
INCYVanguard Health Care Fund 2015-06-30 Reduce-0.15%$88.46 - $110.15
($103.32)
$ 104.761%Reduce -7.50%9,411,543
INCYJoel Greenblatt 2015-06-30 Buy 0.01%$88.46 - $110.15
($103.32)
$ 104.761%New holding10,363
INCYKen Fisher 2015-06-30 Reduce$88.46 - $110.15
($103.32)
$ 104.761%Reduce -7.90%13,695
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INCY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SWAIN PAULA JEVP, Human Resources 2016-11-15Sell10,000$103.261.45view
Huber Reid MEVP, Chief Scientific Officer 2016-11-09Sell2,715$109.95-4.72view
SWAIN PAULA JEVP, Human Resources 2016-10-20Sell10,000$9016.4view
Huber Reid MEVP, Chief Scientific Officer 2016-10-07Sell11,709$96.48.67view
Flannelly Barry PEVP & General Manager US 2016-10-07Sell24,204$978view
SWAIN PAULA JEVP, Human Resources 2016-09-23Sell20,000$9016.4view
Huber Reid MEVP, Chief Scientific Officer 2016-08-02Sell10,000$87.9619.1view
SWAIN PAULA JEVP, Human Resources 2016-07-29Sell60,000$9016.4view
BAKER JULIANDirector, 10% Owner 2016-03-17Buy800,000$63.9863.74view
BAKER JULIANDirector, 10% Owner 2016-02-25Buy64,290$70.7947.99view

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 
Top Insider Trades of the Past Week Feb 19 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 
Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 
Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN Jun 08 2014 
Weekly Insider Sells Highlight: CPN, INCY, GPK, CODE Feb 23 2014 

More From Other Websites
2:37 am Incyte reports 5-year follow-up of the Phase 3 COMFORT-I and COMFORT-II trials; long-term... Dec 06 2016
Hedge Funds Head For Energy Transfer Equity LP (ETE)’s Exits: Spooked by Dakota Pipeline? Dec 05 2016
Incyte CEO: We're building for the long term Dec 05 2016
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data Dec 05 2016
Pooled Analysis of Five-Year Data from Two Phase 3 Studies Further Supports Overall Survival... Dec 04 2016
Does Incyte Corporation (INCY) Represent a Good Addition to Your Portfolio? Nov 28 2016
Intellipharmaceutics Submits NDA for Pain Treatment Rexista Nov 28 2016
Is It Time to Invest in American Water Works Company Inc (AWK)? Nov 27 2016
Merck (MRK) Announces 2.2% Increase in Quarterly Dividend Nov 24 2016
Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod Nov 23 2016
AstraZeneca: FDA Lifts Hold on Head & Neck Cancer Trials Nov 23 2016
Ligand's Partner Retrophin Provides New Data on Sparsentan Nov 22 2016
Aduro Reports Partial Hold Lift on LADD Studies in U.S. Nov 22 2016
Sanofi (SNY) Soliqua Approved for Type 2 Diabetes in Adults Nov 22 2016
[$$] Gilead Now More Likely to Buy Incyte? Nov 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)